6637.Two
6637.TWO is a healthcare equipment company that designs, develops, and sells advanced medical devices and technologies, primarily generating revenue through product sales and service contracts.
Business. 6637.TWO is a healthcare equipment company that designs, develops, and sells advanced medical devices and technologies, primarily generating revenue through product sales and service contracts.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
6637.TWO is a healthcare equipment company that designs, develops, and sells advanced medical devices and technologies, primarily generating revenue through product sales and service contracts.
6637.TWO maintains a relatively strong liquidity position, with a current ratio of 3.04, indicating that it has sufficient current assets to cover its current liabilities. However, the company's operating cash flow is negative at -294,387,000 TWD, which contrasts with a positive free cash flow of 113,571,000 TWD, suggesting that capital expenditures are being funded internally. The company's liquidity is assessed as medium, with a debt-to-equity ratio of 0.41, indicating a moderate level of leverage.
In terms of profitability, 6637.TWO reports a return on equity (ROE) of 16.56% and a return on assets (ROA) of 9.69%, both of which are strong indicators of efficient capital use and asset management. These figures suggest that the company is generating solid returns relative to its equity and total assets, which is favorable compared to the industry's typical performance metrics.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market fluctuates or if regulatory changes impact its operations.
Looking ahead, the company's growth trajectory is expected to remain stable, with no significant changes in revenue or operating performance anticipated in the next fiscal year. The company's capital expenditures are relatively low at -27,667,000 TWD, indicating a conservative approach to reinvestment. This suggests that the company is not aggressively expanding its operations, which may limit its growth potential in the long term.
The risk assessment for 6637.TWO indicates a low potential for dilution, with no significant dilution events reported in the recent financial data. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if cash flow from operations does not improve. The company's debt-to-equity ratio of 0.41 is relatively low, but the negative operating cash flow raises concerns about its ability to service debt obligations.
Recent financial filings and transcripts do not indicate any major events or strategic shifts that would significantly impact the company's operations or financial performance. The company appears to be maintaining a steady course, with no major announcements or changes in leadership reported in the available data.
- 6637.TWO has a strong return on equity (16.56%) and return on assets (9.69%), indicating efficient use of capital and assets.
- The company's liquidity is moderate, with a current ratio of 3.04, but its operating cash flow is negative, which could affect its ability to fund operations.
- The company's debt-to-equity ratio is 0.41, suggesting a relatively low level of leverage, but its net cash position is negative after subtracting total debt.
- 6637.TWO's revenue is concentrated in a single business segment, which may increase its exposure to market and regulatory risks.
- The company's capital expenditures are low, indicating a conservative approach to reinvestment and expansion.
- There are no significant dilution risks reported, but the company's negative operating cash flow raises concerns about its liquidity.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 6637.TWO Market data — financials · 2026-05-27